Healthcare - Medical - Devices - NASDAQ - US
$ 10.05
1 %
$ 239 M
Market Cap
-4.47
P/E
BALANCE SHEET
326 M
ASSETS
121 M
LIABILITIES
205 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Inogen, Inc.
| Current Assets | 207 M |
| Cash & Short-Term Investments | 128 M |
| Receivables | 42.9 M |
| Other Current Assets | 35.7 M |
| Non-Current Assets | 119 M |
| Long-Term Investments | 0 |
| PP&E | 70.7 M |
| Other Non-Current Assets | 48.5 M |
| Current Liabilities | 72.5 M |
| Accounts Payable | 13.5 M |
| Short-Term Debt | 7.31 M |
| Other Current Liabilities | 51.7 M |
| Non-Current Liabilities | 48.9 M |
| Long-Term Debt | 18.3 M |
| Other Non-Current Liabilities | 30.6 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Cash & Cash Equivalents | 125.5 | 187.0 | 235.5 | 212.0 | 198.0 | 196.6 | 143.0 | 92.9 | 66.1 | 56.8 | 13.5 | 15.1 | 3.9 |
| Short Term Investments | 3.0 | 0 | 10.0 | 19.3 | 11.1 | 43.7 | 31.0 | 21.0 | 16.8 | 0 | 0 | 0 | 0 |
| Receivables | 42.9 | 64.4 | 25.8 | 31.8 | 37.3 | 39.7 | 31.4 | 30.8 | 22.0 | 21.5 | 10.3 | 7.0 | 4.4 |
| Inventory | 21.8 | 34.1 | 31.9 | 24.8 | 35.7 | 27.1 | 18.8 | 14.3 | 8.6 | 7.6 | 4.2 | 4.1 | 1.7 |
| Other Current Assets | 13.8 | 19.2 | 26.0 | 17.9 | 10.2 | 7.5 | 4.3 | 2.5 | 1.3 | 6.6 | 4.7 | 0.5 | 0.5 |
| Total Current Assets | 207.1 | 304.6 | 329.2 | 305.7 | 292.2 | 314.6 | 228.5 | 161.5 | 114.8 | 92.5 | 32.8 | 26.7 | 10.4 |
| PP&E | 70.7 | 64.9 | 63.8 | 37.1 | 25.3 | 22.3 | 20.1 | 25.2 | 30.7 | 31.9 | 29.7 | 20.3 | 12.8 |
| Intangible Assets | 34.6 | 0.2 | 60.1 | 68.8 | 77.5 | 3.8 | 4.7 | 0.2 | 0.2 | 0.3 | 0.2 | 0.6 | 0.8 |
| Goodwill | 10.1 | 32.9 | 33.0 | 33.2 | 33.0 | 2.3 | 2.4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | (14.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 3.8 | 2.4 | 3.4 | 2.7 | 4.9 | 2.8 | 0.8 | 0.4 | 97 K | 97 K | 1.8 | 79 K | 52 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 326.2 | 405.0 | 489.5 | 461.9 | 447.3 | 375.9 | 275.1 | 214.0 | 161.3 | 140.1 | 82.4 | 47.6 | 24.1 |
| LIABILITIES | |||||||||||||
| Accounts Payable | 13.5 | 18.2 | 10.3 | 12.5 | 16.4 | 13.7 | 9.5 | 5.7 | 7.4 | 6.7 | 8.8 | 6.0 | 5.7 |
| Short Term Debt | 7.3 | 7.0 | 6.8 | 1.9 | 2.0 | 0 | 0 | 0 | 0.3 | (4.1) | 5.3 | 3.9 | 2.5 |
| Other Current Liabilities | 43.7 | 30.7 | 35.8 | 34.0 | 25.5 | 28.0 | 20.5 | 14.6 | 11.9 | 9.4 | 4.2 | 2.8 | 0.3 |
| Total Current Liabilities | 72.5 | 65.3 | 61.5 | 56.7 | 50.2 | 46.6 | 33.9 | 22.8 | 22.0 | 18.7 | 19.7 | 13.8 | 9.1 |
| Long Term Debt | 18.3 | 19.8 | 23.3 | 8.1 | 4.7 | 0 | 0 | 0 | 0 | 0.3 | 5.4 | 5.1 | 7.1 |
| Deferred Tax Income | 8.5 | 0 | 7.2 | 25 K | 87 K | 0.2 | 0.3 | 0 | 0 | 0.3 | 9.8 | 0 | 0 |
| Other Liabilities | 13.8 | 12.1 | 22.6 | 35.6 | 34.2 | 6.8 | 4.4 | 2.1 | 1.1 | 0.7 | 0.3 | 0.2 | 0.3 |
| Total Liabilities | 121.4 | 107.6 | 119.3 | 112.2 | 102.7 | 65.5 | 48.0 | 32.0 | 27.3 | 21.9 | 26.1 | 19.0 | 16.6 |
| EQUITY | |||||||||||||
| Common Stock | 23 K | 23 K | 23 K | 22 K | 22 K | 22 K | 21 K | 20 K | 20 K | 19 K | 1 K | 1 K | 1 K |
| Retained Earnings | (116.9) | (14.5) | 69.3 | 75.6 | 81.4 | 60.5 | 8.6 | (12.4) | (45.1) | (56.7) | (62.6) | (81.0) | (75.8) |
| Other Accumulative Comprehensive Income/Loss | 1.2 | (0.2) | 1.5 | 0.5 | 87 K | 0.7 | 0.3 | 35 K | 37 K | (25.8) | (16.0) | (10.6) | (6.1) |
| Total Equity | 204.8 | 297.4 | 370.2 | 349.6 | 344.6 | 310.4 | 227.0 | 182.1 | 134.0 | 118.2 | 56.3 | 28.6 | 7.6 |
| Total Liabilities and Equity | 326.2 | 405.0 | 489.5 | 461.9 | 447.3 | 375.9 | 275.1 | 214.0 | 161.3 | 140.1 | 82.4 | 47.6 | 24.1 |
| SHARES OUTSTANDING | |||||||||||||
| Common Shares Outstanding | 23.2 | 22.9 | 22.5 | 22.0 | 21.8 | 22.5 | 20.7 | 20.1 | 19.4 | 16.2 | 18.0 | 14.5 | 14.5 |